Regeneron co-founders George Yancopoulos (L) and Leonard Schleifer (Lev Radin/Pacific Press/LightRocket via Getty Images)

Re­gen­eron will start de­liv­er­ing quar­ter­ly div­i­dends 37 years in­to its ex­is­tence

Re­gen­eron Phar­ma­ceu­ti­cals, one of the orig­i­nal and longest-stand­ing biotech com­pa­nies, is en­ter­ing the div­i­dends are­na for the first time.

The Tar­ry­town, NY-based drug­mak­er sur­prised the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland